Cited by 803Parkinson's Disease Mechanisms and TreatmentsNuclear Receptors and SignalingDeep Brain Stimulation and Movement Disorders

The DOI matches its Crossref record; 173 of the 176 references it cites were found in a registry or an index.

Parkinson’s disease: genetics and pathogenesis

Shulman, Joshua M., De Jager, Philip L., Feany, Mel B.·2011·Annual Review of Pathology: Mechanisms of Disease

DOI 10.1146/annurev-pathol-011110-130242

Open this paper in CoChat — free account

Abstract

Recent investigation into the mechanisms of Parkinson's disease (PD) has generated remarkable insight while simultaneously challenging traditional conceptual frameworks. Although the disease remains defined clinically by its cardinal motor manifestations and pathologically by midbrain dopaminergic cell loss in association with Lewy bodies, it is now recognized that PD has substantially more widespread impact, causing a host of nonmotor symptoms and associated pathology in multiple regions throughout the nervous system. Further, the discovery and validation of PD-susceptibility genes contradict the historical view that environmental factors predominate, and blur distinctions between familial and sporadic disease. Genetic advances have also promoted the development of improved animal models, highlighted responsible molecular pathways, and revealed mechanistic overlap with other neurodegenerative disorders. In this review, we synthesize emerging lessons on PD pathogenesis from clinical, pathological, and genetic studies toward a unified concept of the disorder that may accelerate the design and testing of the next generation of PD therapies.

Integrity signals

Registry

Crossref · 10.1146/annurev-pathol-011110-130242

Cites

173 of 173 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Staging of brain pathology related to sporadic Parkinson’s disease
Braak, H., Tredici, K. D., Rüb, U., de Vos, R. A. I., Jansen Steur, E. N. H., & Braak, E. (2003) · Neurobiology of Aging · doi:10.1016/s0197-4580(02)00065-9 · Cited by 10,777
α-Synuclein in Lewy bodies
Spillantini, M. G., Schmidt, M. L., Lee, V. M.-Y., Trojanowski, J. Q., Jakes, R., & Goedert, M. (1997) · Nature · doi:10.1038/42166 · Cited by 8,382
Mutation in the α-Synuclein Gene Identified in Families with Parkinson's Disease
Polymeropoulos, M. H., Lavedan, C., Leroy, E., Ide, S. E., Dehejia, A., Dutra, A., Pike, B., Root, H., Rubenstein, J., Boyer, R., et al. (1997) · Science · doi:10.1126/science.276.5321.2045 · Cited by 8,240
Parkinson's Disease
Dauer, W., & Przedborski, S. (2003) · Neuron · doi:10.1016/s0896-6273(03)00568-3 · Cited by 5,469
Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism
Kitada, T., Asakawa, S., Hattori, N., Matsumine, H., Yamamura, Y., Minoshima, S., Yokochi, M., Mizuno, Y., & Shimizu, N. (1998) · Nature · doi:10.1038/33416 · Cited by 5,227
Diagnosis and management of dementia with Lewy bodies: Third report of the DLB consortium
McKeith, I. G., Dickson, D. W., Lowe, J., Emre, M., O'Brien, J. T., Feldman, H., Cummings, J., Duda, J. E., Lippa, C., Perry, E. K., et al. (2005) · Neurology · doi:10.1212/01.wnl.0000187889.17253.b1 · Cited by 5,069
Chronic Parkinsonism in Humans Due to a Product of Meperidine-Analog Synthesis
Langston, J. W., Ballard, P., Tetrud, J. W., & Irwin, I. (1983) · Science · doi:10.1126/science.6823561 · Cited by 4,914
α-Synuclein Locus Triplication Causes Parkinson's Disease
Singleton, A. B., Farrer, M., Johnson, J., Singleton, A., Hague, S., Kachergus, J., Hulihan, M., Peuralinna, T., Dutra, A., Nussbaum, R., et al. (2003) · Science · doi:10.1126/science.1090278 · Cited by 4,383
Epidemiology of Parkinson's disease
de Lau, L. M., & Breteler, M. M. (2006) · The Lancet Neurology · doi:10.1016/s1474-4422(06)70471-9 · Cited by 4,110
AlaSOPro mutation in the gene encoding α-synuclein in Parkinson's disease
Krüger, R., Kuhn, W., Müller, T., Woitalla, D., Graeber, M., Kösel, S., Przuntek, H., Epplen, J. T., Schols, L., & Riess, O. (1998) · Nature Genetics · doi:10.1038/ng0298-106 · Cited by 3,836

Show all 176 references

Research works printed but not linked: 4

Parkinson J, 1817, An Essay on the Shaking Palsy
Priyadarshi A, 2000, Neurotoxicology, 21, 435
Gilks W, 2005, Lancet, 365, 415
Nichols WC, 2005, Lancet, 365, 410

Sorted by citations

Items 101–200 of 803

c-Abl and Parkinson’s Disease: Mechanisms and Therapeutic Potential
Brahmachari, S., Karuppagounder, S. S., Ge, P., Lee, S., Dawson, V. L., Dawson, T. M., & Ko, H. S. (2017) · Journal of Parkinson s Disease · doi:10.3233/jpd-171191 · Cited by 101
Synaptotagmin-11 is a critical mediator of parkin-linked neurotoxicity and Parkinson’s disease-like pathology
Wang, C., Kang, X., Zhou, L., Chai, Z., Wu, Q., Huang, R., Xu, H., Hu, M., Sun, X., Sun, S., et al. (2018) · Nature Communications · doi:10.1038/s41467-017-02593-y · Cited by 103
Identification of sixteen novel candidate genes for late onset Parkinson’s disease
Gialluisi, A., Reccia, M. G., Modugno, N., Nutile, T., Lombardi, A., Giovannantonio, L. G. D., Pietracupa, S., Ruggiero, D., Scala, S., Gambardella, S., et al. (2021) · Molecular Neurodegeneration · doi:10.1186/s13024-021-00455-2 · Cited by 106
Self-citation
The microbiota–microglia axis in central nervous system disorders
Mossad, O., & Erny, D. (2020) · Brain Pathology · doi:10.1111/bpa.12908 · Cited by 98
PINK1-dependent phosphorylation of PINK1 and Parkin is essential for mitochondrial quality control
Zhuang, N., Li, L., Chen, S., & Wang, T. (2016) · Cell Death and Disease · doi:10.1038/cddis.2016.396 · Cited by 96
Computational Studies Applied to Flavonoids against Alzheimer’s and Parkinson’s Diseases
Monteiro, A., Viana, J. D. O., Nayarisseri, A., Ernestine, N., Mendonça, F. J. B., Scotti, M. T., & Scotti, L. (2018) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2018/7912765 · Cited by 101
Molecular Features Underlying Neurodegeneration Identified through In Vitro Modeling of Genetically Diverse Parkinson’s Disease Patients
Lin, L., Göke, J., Cukuroglu, E., Dranias, M. R., VanDongen, A. M. J., & Stanton, L. W. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.05.022 · Cited by 95
Preventing α-synuclein aggregation: The role of the small heat-shock molecular chaperone proteins
Cox, D., Carver, J. A., & Ecroyd, H. W. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2014.06.024 · Cited by 98
Mitochondria-Targeted Protective Compounds in Parkinson’s and Alzheimer’s Diseases
Fernández‐Moriano, C., González‐Burgos, E., & Gómez-Serranillos, M. P. (2015) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2015/408927 · Cited by 100
Neuroinflammation in Multiple System Atrophy: Response to and Cause of α-Synuclein Aggregation
Vieira, B. D. M., Radford, R. A., Chung, R. S., Guillemin, G. J., & Pountney, D. L. (2015) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2015.00437 · Cited by 93
Neuroprotective potential of chrysin in Parkinson's disease: Molecular mechanisms and clinical implications
Angelopoulou, E., Pyrgelis, E.-S., & Piperi, C. (2019) · Neurochemistry International · doi:10.1016/j.neuint.2019.104612 · Cited by 93
Touchscreen typing-pattern analysis for detecting fine motor skills decline in early-stage Parkinson's disease
Iakovakis, D., Hadjidimitriou, S., Charisis, V., Bostantzopoulou, S., Katsarou, Z., & Hadjileontiadis, L. J. (2018) · Scientific Reports · doi:10.1038/s41598-018-25999-0 · Cited by 92
The neurotoxicity of iron, copper and cobalt in Parkinson’s disease through ROS-mediated mechanisms
Lan, A. P., Chen, J., Chai, Z., & Hu, Y. (2016) · BioMetals · doi:10.1007/s10534-016-9942-4 · Cited by 92
A dopamine receptor contributes to paraquat-induced neurotoxicity in Drosophila
Cassar, M., Issa, A.-R., Riemensperger, T. D., Petitgas, C., Rival, T., Coulom, H., Torres, M., Han, K., & Birman, S. (2014) · Human Molecular Genetics · doi:10.1093/hmg/ddu430 · Cited by 90
ER-stress-associated functional link between Parkin and DJ-1 via a transcriptional cascade involving the tumor suppressor p53 and the spliced X-box binding protein XBP-1
Duplan, E., Giaime, E., Viotti, J., Sévalle, J., Corti, O., Brice, A., Ariga, H., Qi, L., Checler, F., & da Costa, C. A. (2013) · Journal of Cell Science · doi:10.1242/jcs.127340 · Cited by 91
Lmx1a and Lmx1b regulate mitochondrial functions and survival of adult midbrain dopaminergic neurons
Doucet-Beaupré, H., Gilbert, C., Profes, M. S., Chabrat, A., Pacelli, C., Giguère, N., Rioux, V., Charest, J., Deng, Q., Laguna, A., et al. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1520387113 · Cited by 94
Gallic Acid Protects 6-OHDA Induced Neurotoxicity by Attenuating Oxidative Stress in Human Dopaminergic Cell Line
Chandrasekhar, Y., Kumar, G. P., Ramya, E. M., & Anilakumar, K. R. (2018) · Neurochemical Research · doi:10.1007/s11064-018-2530-y · Cited by 90
Vitamin A and Carotenoids and the Risk of Parkinson's Disease: A Systematic Review and Meta-Analysis
Takeda, A., Nyssen, O. P., Syed, A., Jansen, E. H. J. M., Bueno-de-Mesquita, B. H., & Gallo, V. (2013) · Neuroepidemiology · doi:10.1159/000355849 · Cited by 87
Dysphagia in the Elderly
Khan, A., Carmona, R., & Traube, M. (2013) · Clinics in Geriatric Medicine · doi:10.1016/j.cger.2013.10.009 · Cited by 86
Oxidative Stress in Genetic Mouse Models of Parkinson’s Disease
Varçin, M., Bentea, E., Michotte, Y. M., & Sarre, S. (2012) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2012/624925 · Cited by 86
Parkinson disease polygenic risk score is associated with Parkinson disease status and age at onset but not with alpha-synuclein cerebrospinal fluid levels
Ibáñez, L., Dube, U., Saef, B. A., Budde, J., Black, K., Medvedeva, A., Del‐Aguila, J. L., Davis, A. A., Perlmutter, J. S., Harari, O., et al. (2017) · BMC Neurology · doi:10.1186/s12883-017-0978-z · Cited by 85
The Role of the Blood Brain Barrier in Neurodegenerative Disorders and their Treatment
Palmer, A. M. (2011) · Journal of Alzheimer s Disease · doi:10.3233/jad-2011-110368 · Cited by 89
Genetics of Parkinson’s disease and related disorders
Zhang, P.-L., Chen, Y., Zhang, C.-H., Wang, Y., & Fernández-Fúnez, P. (2017) · Journal of Medical Genetics · doi:10.1136/jmedgenet-2017-105047 · Cited by 93
Naringin and Naringenin Polyphenols in Neurological Diseases: Understandings from a Therapeutic Viewpoint
Emran, T. B., Islam, F., Nath, N., Sutradhar, H., Das, R. C., Mitra, S., Alshahrani, M. M., Alhasaniah, A. H., & Sharma, R. (2022) · Life · doi:10.3390/life13010099 · Cited by 86
The role of serotonergic, adrenergic and dopaminergic receptors in antidepressant-like effect
Pytka, K., Podkowa, K., Rapacz, A., Podkowa, A., Żmudzka, E., Olczyk, A., Sapa, J., & Filipek, B. (2015) · Pharmacological Reports · doi:10.1016/j.pharep.2015.08.007 · Cited by 88
Effects of impaired membrane interactions on α-synuclein aggregation and neurotoxicity
Ysselstein, D., Joshi, M. K., Mishra, V. R., Griggs, A. M., Asiago, J. M., McCabe, G. P., Stanciu, L., Post, C. B., & Rochet, J. (2015) · Neurobiology of Disease · doi:10.1016/j.nbd.2015.04.007 · Cited by 86
Molecular Insights into Parkinson's Disease
Rochet, J., Hay, B. A., & Guo, M. (2012) · Progress in molecular biology and translational science · doi:10.1016/b978-0-12-385883-2.00011-4 · Cited by 87
Caspase-1 Deficiency Alleviates Dopaminergic Neuronal Death via Inhibiting Caspase-7/AIF Pathway in MPTP/p Mouse Model of Parkinson’s Disease
Qiao, C., Zhang, L., Sun, X., Ding, J., Lu, M., & Hu, G. (2016) · Molecular Neurobiology · doi:10.1007/s12035-016-9980-5 · Cited by 84
Axin-2 knockdown promote mitochondrial biogenesis and dopaminergic neurogenesis by regulating Wnt/β-catenin signaling in rat model of Parkinson's disease
Singh, S., Mishra, A., Mohanbhai, S. J., Tiwari, V., Chaturvedi, R. K., Khurana, S., & Shukla, S. (2018) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2018.08.033 · Cited by 82
APOE , MAPT , and COMT and Parkinson’s Disease Susceptibility and Cognitive Symptom Progression
Paul, K. C., Rausch, R., Creek, M. M., Sinsheimer, J. S., Bronstein, J. M., Bordelon, Y. M., & Ritz, B. R. (2016) · Journal of Parkinson s Disease · doi:10.3233/jpd-150762 · Cited by 79
Epigenetics in Parkinson’s Disease
Pavlou, M. A. S., & Outeiro, T. F. (2017) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-53889-1_19 · Cited by 85
α-synuclein impairs autophagosome maturation through abnormal actin stabilization
Sarkar, S., Olsen, A. L., Sygnecka, K., Lohr, K. M., & Feany, M. Β. (2021) · PLoS Genetics · doi:10.1371/journal.pgen.1009359 · Cited by 82
Self-citation
Therapeutic utility of mesenchymal stromal cell (MSC)-based approaches in chronic neurodegeneration: a glimpse into underlying mechanisms, current status, and prospects
Rahbaran, M., Zekiy, A. O., Bahramali, M., Jahangir, M., Mardasi, M., Sakhaei, D., Thangavelu, L. P., Shomali, N., Zamani, M., Mohammadi, A., et al. (2022) · Cellular & Molecular Biology Letters · doi:10.1186/s11658-022-00359-z · Cited by 82
Carboxyfullerene neuroprotection postinjury in Parkinsonian nonhuman primates
Dugan, L. L., Tian, L., Quick, K. L., Hardt, J. I., Karimi, M., Brown, C., Loftin, S. K., Flores, H., Moerlein, S. M., Polich, J. M., et al. (2014) · Annals of Neurology · doi:10.1002/ana.24220 · Cited by 81
Hesperidin attenuates iron-induced oxidative damage and dopamine depletion in Drosophila melanogaster model of Parkinson's disease
Poetini, M. R., Araújo, S. M., de Paula, M. T., Bortolotto, V. C., Meichtry, L. B., de Almeida, F. P., Jessé, C. R., Kunz, S. N., & Prigol, M. (2017) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2017.11.018 · Cited by 79
The Novel Dual GLP-1/GIP Receptor Agonist DA-CH5 Is Superior to Single GLP-1 Receptor Agonists in the MPTP Model of Parkinson’s Disease
Zhang, L., Zhang, L., Li, Y., Li, L., Melchiorsen, J. U., ROSENKILDE, M. M., & Hölscher, C. (2020) · Journal of Parkinson s Disease · doi:10.3233/jpd-191768 · Cited by 80
Valency and Binding Affinity Variations Can Regulate the Multilayered Organization of Protein Condensates with Many Components
Sanchez‐Burgos, I., Espinosa, J. R., Joseph, J. A., & Collepardo‐Guevara, R. (2021) · Biomolecules · doi:10.3390/biom11020278 · Cited by 76
The physiology and pathobiology of human kallikrein-related peptidase 6 (KLK6)
Bayani, J., & Diamandis, E. P. (2011) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm.2011.750 · Cited by 81
Proteolytic Cleavage of Extracellular α-Synuclein by Plasmin
Kim, K. S., Choi, Y. R., Park, J. Y., Lee, J.-H., Kim, D. K., Lee, S., Paik, S. R., Jou, I., & Park, S. M. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.348128 · Cited by 81
Neurotrophin Signaling and Stem Cells—Implications for Neurodegenerative Diseases and Stem Cell Therapy
Pramanik, S., Sulistio, Y. A., & Heese, K. (2016) · Molecular Neurobiology · doi:10.1007/s12035-016-0214-7 · Cited by 77
Hesperidin Ameliorates Anxiety-Depressive-Like Behavior in 6-OHDA Model of Parkinson’s Disease by Regulating Striatal Cytokine and Neurotrophic Factors Levels and Dopaminergic Innervation Loss in the Striatum of Mice
Antunes, M. S., Souza, L. C., Ladd, F. V. L., Ladd, A. A. B. L., Moreira, A. L., Bortolotto, V. C., Poetini, M. R., Araújo, S. M., Prigol, M., Nogueira, C. W., et al. (2020) · Molecular Neurobiology · doi:10.1007/s12035-020-01940-3 · Cited by 76
Incident parkinsonism in older adults without Parkinson disease
Buchman, A. S., Leurgans, S. E., Yu, L., Wilson, R. S., Lim, A. S. P., James, B. D., Shulman, J. M., & Bennett, D. A. (2016) · Neurology · doi:10.1212/wnl.0000000000003059 · Cited by 74
Self-citation
The Role of Protein Persulfidation in Brain Aging and Neurodegeneration
Petrovic, D., Kouroussis, E., Vignane, T., & Filipović, M. R. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.674135 · Cited by 75
Studies of neurodegenerative diseases using Drosophila and the development of novel approaches for their analysis
Nitta, Y., & Sugie, A. (2022) · Fly · doi:10.1080/19336934.2022.2087484 · Cited by 81
Can Trehalose Prevent Neurodegeneration? Insights from Experimental Studies
Emanuele, E. (2014) · Current Drug Targets · doi:10.2174/1389450115666140225104705 · Cited by 75
Increased Risk of Parkinson's Disease in Patients With Obstructive Sleep Apnea
Yeh, N.-C., Tien, K., Yang, C.-M., Wang, J., & Weng, S. (2016) · Medicine · doi:10.1097/md.0000000000002293 · Cited by 74
Novel incretin analogues improve autophagy and protect from mitochondrial stress induced by rotenone in SH ‐ SY 5Y cells
Jalewa, J., Sharma, M. K., & Hölscher, C. (2016) · Journal of Neurochemistry · doi:10.1111/jnc.13736 · Cited by 77
MicroRNAs in Parkinson's disease and emerging therapeutic targets
Peplow, P., & Martinez, B. (2017) · Neural Regeneration Research · doi:10.4103/1673-5374.221147 · Cited by 73
Mitochondrial metabolism in neural stem cells and implications for neurodevelopmental and neurodegenerative diseases
Garone, C., Giorgio, F. D., & Carli, S. (2024) · Journal of Translational Medicine · doi:10.1186/s12967-024-05041-w · Cited by 80
Toward stem cell-based phenotypic screens for neurodegenerative diseases
Khurana, V., Tardiff, D. F., Chung, C. Y., & Lindquist, S. L. (2015) · Nature Reviews Neurology · doi:10.1038/nrneurol.2015.79 · Cited by 72
MicroRNAs in Parkinson’s disease
Singh, A., & Sen, D. (2017) · Experimental Brain Research · doi:10.1007/s00221-017-4989-1 · Cited by 73
Anti-Parkinson's disease activity of phenolic acids from Eucommia ulmoides Oliver leaf extracts and their autophagy activation mechanism
Zhang, S., Yu, Z., Xia, J., Zhang, X., Liu, K., Attila Gabor, S. I. K., & Jin, M. (2019) · Food & Function · doi:10.1039/c9fo02288k · Cited by 72
Clinical applications of schizophrenia genetics: genetic diagnosis, risk, and counseling in the molecular era
Bassett, A. S., & Costain, G. (2012) · The Application of Clinical Genetics · doi:10.2147/tacg.s21953 · Cited by 71
Multitarget effects of Korean Red Ginseng in animal model of Parkinson's disease: antiapoptosis, antioxidant, antiinflammation, and maintenance of blood–brain barrier integrity
Choi, J. H., Jang, M., Nah, S.-Y., Oh, S., & Cho, I. (2018) · Journal of Ginseng Research · doi:10.1016/j.jgr.2018.01.002 · Cited by 72
Substantia Nigra Volume Loss Before Basal Forebrain Degeneration in Early Parkinson Disease
Ziegler, D. A., Wonderlick, J. S., Ashourian, P., Hansen, L. A., Young, J. C., Murphy, A. J., Koppuzha, C. K., Growdon, J. H., & Corkin, S. (2012) · JAMA Neurology · doi:10.1001/jamaneurol.2013.597 · Cited by 71
Genetic therapy for the nervous system
Bowers, W. J., Breakefield, X. O., & Sena‐Esteves, M. (2011) · Human Molecular Genetics · doi:10.1093/hmg/ddr110 · Cited by 72
Analysis of neural subtypes reveals selective mitochondrial dysfunction in dopaminergic neurons from parkin mutants
Burman, J. L., Yu, S., Poole, A. C., Decal, R. B., & Pallanck, L. J. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1120688109 · Cited by 74
The contribution of mutantGBAto the development of Parkinson disease inDrosophila
Maor, G., Cabasso, O., Krivoruk, O., Rodriguez, J., Steller, H., Segal, D., & Horowitz, M. (2016) · Human Molecular Genetics · doi:10.1093/hmg/ddw129 · Cited by 73
Induced pluripotent stem cells: a tool for modeling Parkinson’s disease
Bose, A., Petsko, G. A., & Studer, L. (2022) · Trends in Neurosciences · doi:10.1016/j.tins.2022.05.001 · Cited by 74
Gene expression profiling for human iPS-derived motor neurons from sporadic ALS patients reveals a strong association between mitochondrial functions and neurodegeneration
Alves, C. J., Dariolli, R., Jorge, F. M. H., Monteiro, M. R., Maximino, J. R., Martins, R. S., Strauss, B. E., Krieger, J. E., Callegaro, D., & Chadi, G. (2015) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2015.00289 · Cited by 71
Acrylamide induces locomotor defects and degeneration of dopamine neurons in Caenorhabditis elegans
Li, J., Li, D., Yang, Y., Xu, T., Li, P., & He, D. (2015) · Journal of Applied Toxicology · doi:10.1002/jat.3144 · Cited by 71
Parkinsonism in Older Adults and Its Association With Adverse Health Outcomes and Neuropathology
Buchman, A. S., Wilson, R. S., Shulman, J. M., Leurgans, S. E., Schneider, J. A., & Bennett, D. A. (2015) · The Journals of Gerontology Series A · doi:10.1093/gerona/glv153 · Cited by 72
Self-citation
Effect of intranasal stem cell administration on the nigrostriatal system in a mouse model of Parkinson's disease
Salama, M., Sobh, M., Emam, M., Abdalla, A. R., Sabry, D., El‐Gamal, M., Lotfy, A., Elhusseiny, M., Sobh, M. A. K., Shalash, A., et al. (2017) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2017.4073 · Cited by 70
Aberrant Alternative Splicing Events in Parkinson's Disease
Fu, R., Liu, S., Huang, S.-J., Chen, H., Chen, P.-R., Lin, Y.-H., Ho, Y., Chang, W.-L., Tsai, C., Shyu, W., et al. (2013) · Cell Transplantation · doi:10.3727/096368912x655154 · Cited by 69
Phloroglucinol Attenuates Motor Functional Deficits in an Animal Model of Parkinson's Disease by Enhancing Nrf2 Activity
Ryu, J., Zhang, R., Hong, B.-H., Yang, E.-J., Kang, K. A., Choi, M., Kim, K. C., Noh, S.-J., Kim, H. S., Lee, N.-H., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0071178 · Cited by 69
Intracellular delivery of Parkin rescues neurons from accumulation of damaged mitochondria and pathological α-synuclein
chung, E., Choi, Y., Park, J., Nah, W., Park, J.-H., Jung, Y., Lee, J., Lee, H., Park, S., Hwang, S., et al. (2020) · Science Advances · doi:10.1126/sciadv.aba1193 · Cited by 69
Akt as a Victim, Villain and Potential Hero in Parkinson’s Disease Pathophysiology and Treatment
Greene, L. A., Levy, O., & Malagelada, C. (2011) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-011-9671-8 · Cited by 69
Recent advances in biosensors for neurodegenerative disease detection
Ganesh, H. V. S., Chow, A. M., & Kerman, K. (2016) · TrAC Trends in Analytical Chemistry · doi:10.1016/j.trac.2016.02.012 · Cited by 69
Parkin interacting substrate zinc finger protein 746 is a pathological mediator in Parkinson’s disease
Brahmachari, S., Lee, S., Kim, S., Yuan, C., Karuppagounder, S. S., Ge, P., Shi, R., Kim, E. J., Liu, A., Kim, D., et al. (2019) · Brain · doi:10.1093/brain/awz172 · Cited by 70
Reference SVA insertion polymorphisms are associated with Parkinson’s Disease progression and differential gene expression
Pfaff, A. L., Bubb, V. J., Quinn, J. P., & Kõks, S. (2021) · npj Parkinson s Disease · doi:10.1038/s41531-021-00189-4 · Cited by 66
Next-generation sequencing reveals substantial genetic contribution to dementia with Lewy bodies
Geiger, J. T., Ding, J., Crain, B. J., Pletniková, O., Letson, C., Dawson, T. M., Rosenthal, L. S., Pantelyat, A. Y., Gibbs, J. R., Albert, M., et al. (2016) · Neurobiology of Disease · doi:10.1016/j.nbd.2016.06.004 · Cited by 66
Harnessing neuroplasticity: modern approaches and clinical future
Sasmita, A. O., Kuruvilla, J., & Ling, A. P. K. (2018) · International Journal of Neuroscience · doi:10.1080/00207454.2018.1466781 · Cited by 69
Chronic renal dysfunction, proteinuria, and risk of Parkinson's disease in the elderly
Nam, G. E., Kim, N. H., Han, K., Choi, K. M., Chung, H. S., Kim, J. W., Han, B., Cho, S.-J., Jung, S. J., Yu, J. H., et al. (2019) · Movement Disorders · doi:10.1002/mds.27704 · Cited by 64
The Diagnostic and Differential Diagnosis Utility of Cerebrospinal Fluidα-Synuclein Levels in Parkinson’s Disease: A Meta-Analysis
Zhou, B., Wen, M., Yu, W., Zhang, C., & Jiao, L. (2015) · Parkinson s Disease · doi:10.1155/2015/567386 · Cited by 65
Loss of PINK1 enhances neurodegeneration in a mouse model of Parkinson's disease triggered by mitochondrial stress
Moisoi, N., Fedele, V., Edwards, J., & Martins, L. M. (2013) · Neuropharmacology · doi:10.1016/j.neuropharm.2013.10.009 · Cited by 68
Targeting heat shock proteins to modulate α-synuclein toxicity
Jones, D. R., Moussaud, S., & McLean, P. J. (2013) · Therapeutic Advances in Neurological Disorders · doi:10.1177/1756285613493469 · Cited by 70
Apelin-36 mediates neuroprotective effects by regulating oxidative stress, autophagy and apoptosis in MPTP-induced Parkinson’s disease model mice
Zhu, J., Gao, W., Shan, X., Wang, C., Wang, H., Shao, Z., Dou, S., Jiang, Y., Wang, C., & Cheng, B. (2020) · Brain Research · doi:10.1016/j.brainres.2019.146493 · Cited by 65
The benefits of exercise on structural and functional plasticity in the rodent hippocampus of different disease models.
Patten, A. R., Yau, S. Y., Fontaine, C. J., Meconi, A., Wortman, R. C., & Christie, B. R. (2015) · Brain Plasticity · doi:10.3233/bpl-150016 · Cited by 64
Astroglial and microglial contributions to iron metabolism disturbance in Parkinson's disease
Song, N., Wang, J., Jiang, H. F., & Xie, J. (2018) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2018.01.008 · Cited by 63
miR‐29c‐3p inhibits microglial NLRP3 inflammasome activation by targeting NFAT5 in Parkinson's disease
Wang, R., Li, Q., He, Y., Yang, Y., Ma, Q., & Li, C. (2020) · Genes to Cells · doi:10.1111/gtc.12764 · Cited by 64
Cas9-mediated replacement of expanded CAG repeats in a pig model of Huntington’s disease
Yan, S., Zheng, X., Lin, Y., Li, C., Liu, Z., Li, J., Tu, Z., Zhao, Y., Huang, C., Chen, Y., et al. (2023) · Nature Biomedical Engineering · doi:10.1038/s41551-023-01007-3 · Cited by 69
LRRK2 expression is enriched in the striosomal compartment of mouse striatum
Mandemakers, W. J., Snellinx, A., O’Neill, M. J., & Strooper, B. D. (2012) · Neurobiology of Disease · doi:10.1016/j.nbd.2012.07.017 · Cited by 67
Chronic mild stress accelerates the progression of Parkinson's disease in A53T α-synuclein transgenic mice
Wu, Q., Yang, X., Zhang, Y., Zhang, L., & Feng, L. (2016) · Experimental Neurology · doi:10.1016/j.expneurol.2016.09.004 · Cited by 66
Tris(2-chloroethyl) phosphate (TCEP) and tris(2-chloropropyl) phosphate (TCPP) induce locomotor deficits and dopaminergic degeneration in Caenorhabditis elegans
Xu, T., Li, P., Wu, S., Lei, L., & He, D. (2016) · Toxicology Research · doi:10.1039/c6tx00306k · Cited by 64
Effects of dopamine on reinforcement learning and consolidation in Parkinson’s disease
Grogan, J. P., Tsivos, D., Smith, L., Knight, B. E., Bogacz, R., Whone, A., & Coulthard, E. J. (2017) · eLife · doi:10.7554/elife.26801 · Cited by 63
α-Synuclein impairs ferritinophagy in the retinal pigment epithelium: Implications for retinal iron dyshomeostasis in Parkinson’s disease
Baksi, S., & Singh, N. (2017) · Scientific Reports · doi:10.1038/s41598-017-12862-x · Cited by 64
Emerging polymeric biomaterials and manufacturing-based tissue engineering approaches for neuro regeneration-A critical review on recent effective approaches
Akhtar, A., Rad, V. F., Moradi, A., Yar, M., & Bazzar, M. (2022) · Smart Materials in Medicine · doi:10.1016/j.smaim.2022.11.007 · Cited by 65
Alpha-synuclein modulates retinal iron homeostasis by facilitating the uptake of transferrin-bound iron: Implications for visual manifestations of Parkinson's disease
Baksi, S., Tripathi, A. K., & Singh, N. (2016) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2016.06.025 · Cited by 64
"Metal elements and pesticides as risk factors for Parkinson's disease - A review"
Ullah, I., Zhao, L., Yang, H. T., Muhammad, F., Alwayli, D., Wang, X., & Li, H. (2021) · Toxicology Reports · doi:10.1016/j.toxrep.2021.03.009 · Cited by 72
Impaired Wnt signaling in dopamine containing neurons is associated with pathogenesis in a rotenone triggered Drosophila Parkinson’s disease model
Stephano, F., Nolte, S. S., Hoffmann, J., El‐Kholy, S., von Frieling, J., Bruchhaus, I., Fink, C., & Roeder, T. (2018) · Scientific Reports · doi:10.1038/s41598-018-20836-w · Cited by 64
Mitochondrial Disturbances, Tryptophan Metabolites and Neurodegeneration: Medicinal Chemistry Aspects
Szalárdy, L., Klivènyi, P., Zádori, D., Fülöp, F., Toldi, J., & Vécsei, L. (2012) · Current Medicinal Chemistry · doi:10.2174/092986712800167365 · Cited by 60
The Pharmacology of Regenerative Medicine
Christ, G. J., Saul, J. M., Furth, M. E., & Andersson, K. (2013) · Pharmacological Reviews · doi:10.1124/pr.112.007393 · Cited by 63
Proteostasis and Movement Disorders: Parkinson's Disease and Amyotrophic Lateral SclerosisPreprint
Bosco, D. A., LaVoie, M. J., Petsko, G. A., & Ringe, D. (2011) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a007500 · Cited by 61
MiR‐29c protects against inflammation and apoptosis in Parkinson's disease model in vivo and in vitro by targeting SP1
Wang, R., Yang, Y., Wang, H., He, Y., & Li, C. (2019) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/1440-1681.13212 · Cited by 60
F-Box Only Protein 7 Gene in Parkinsonian-Pyramidal Disease
Deng, H., Liang, H. W., & Jankovic, J. J. (2013) · JAMA Neurology · doi:10.1001/jamaneurol.2013.572 · Cited by 60
Genetic analysis of the ATG7 gene promoter in sporadic Parkinson's disease
Chen, D., Pang, S., Feng, X., Huang, W., Hawley, R. G., & Yan, B. (2013) · Neuroscience Letters · doi:10.1016/j.neulet.2012.12.039 · Cited by 59
Occupational exposures and Parkinson's disease mortality in a prospective Dutch cohort
Brouwer, M., Koeman, T., van den Brandt, P. A., Kromhout, H., Schouten, L. J., Peters, S., Huss, A., & Vermeulen, R. C. H. (2015) · Occupational and Environmental Medicine · doi:10.1136/oemed-2014-102209 · Cited by 59
A NETWORK VIEW ON PARKINSON'S DISEASE
Chandrasekaran, S., & Bonchev, D. (2013) · Computational and Structural Biotechnology Journal · doi:10.5936/csbj.201304004 · Cited by 58
Abnormal B-Cell and Tfh-Cell Profiles in Patients With Parkinson Disease
Li, R., Tropea, T. F., Baratta, L. R., Zuroff, L. R., Diaz‐Ortiz, M. E., Zhang, B., Shinoda, K., Rezk, A., Alcalay, R. N., Chen‐Plotkin, A. S., et al. (2021) · Neurology Neuroimmunology & Neuroinflammation · doi:10.1212/nxi.0000000000001125 · Cited by 60
Neurobiology of cognitive impairment in Parkinson’s disease
Jellinger, K. A. (2012) · Expert Review of Neurotherapeutics · doi:10.1586/ern.12.131 · Cited by 59

Authors: Shulman, J. M., De Jager, P. L., & Feany, M. B.
Affiliations: Broad Institute (US)
Departments of Neurology, Boston, Massachusetts 02115;
Departments of Pathology, Brigham and Women's Hospital, Boston, Massachusetts 02115;
ORCID: Shulman, Joshua M.
Venue: Annual Review of Pathology: Mechanisms of Disease
Publisher: Annual Reviews
Published: 2011-02-28
Volume: 6
Issue: 1
Pages: 193-222
ISSN: 1553-4006 (ISSN-L)
1553-4014
DOI: 10.1146/annurev-pathol-011110-130242
OpenAlex: W2129917779
Cited by: 801
References: 176
Citations by year: 2026: 10 · 2025: 21 · 2024: 42 · 2023: 34 · 2022: 64 · 2021: 64 · 2020: 46 · 2019: 59 · 2018: 54 · 2017: 59 · 2016: 74 · 2015: 64 · 2014: 56 · 2013: 65 · 2012: 52
FWCI: 8.22
Type: journal article
Language: en
Open access: closed
Locations: Annual Review of Pathology Mechanisms of Disease (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nuclear Receptors and Signaling
Health Sciences › Medicine › Clinical Neurology › Deep Brain Stimulation and Movement Disorders
Keywords: Parkinson's disease, susceptibility genes, pathogenesis, dopaminergic neuron loss, Lewy bodies, non-motor symptoms, animal models, neurodegeneration, molecular pathways
MeSH terms: Animals, Humans, Parkinson Disease, Lewy Bodies, Genetic Predisposition to Disease

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Parkinson’s disease: genetics and pathogenesis

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks